Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
Want to see BCLI full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Brainstorm Cell Therapeutics is a Sell.
Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.76, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.75, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics (BCLI) Pivot Points
Classic
0.76
0.77
0.79
0.80
0.82
0.83
0.85
Fibonacci
0.77
0.78
0.79
0.80
0.81
0.82
0.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Brainstorm Cell Therapeutics (BCLI) Moving Averages
MA5
0.80Buy
0.80Buy
MA10
0.79Buy
0.78Buy
MA20
0.75Buy
0.76Buy
MA50
0.76Buy
0.75Buy
MA100
0.73Buy
0.74Buy
MA200
0.69Buy
0.73Buy
Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.78, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.74, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Buy.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.76, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.73, creating a Buy signal.
Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.69, creating a Buy signal.
Brainstorm Cell Therapeutics (BCLI) Technical Indicators
RSI (14)
58.44
Neutral
STOCH (9,6)
63.11
Neutral
STOCHRSI (14)
77.19
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
31.16
Neutral
Williams %R
-11.76
Sell
CCI (14)
140.57
Sell
ATR (14)
0.08
-
Ultimate Oscillator
49.72
Neutral
ROC
20.29
Buy
Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 58.44, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 31.16, creating a Neutral signal.
Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is 140.57, creating a Sell signal.
Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is 20.29, creating a Buy signal.
FAQ
Is BCLI a Buy, Hold, or Sell?
Based on BCLI’s technical indicators, BCLI is a Buy.
What is BCLI’s RSI (14)?
BCLI’s RSI (14) is 58.44, which suggests BCLI is a Neutral.
What is BCLI’s MACD?
BCLI’s MACD is 0.02, which suggests BCLI is a Sell.
What is BCLI’s 5-day moving average?
BCLI’s 5-day moving average is 0.80, which suggests BCLI is a Buy.
What is BCLI’s 20-day moving average?
BCLI 20-day moving average is 0.75, which suggests BCLI is a Buy.
What is BCLI’s 50-day moving average?
BCLI’s 50-day moving average is 0.76, which suggests BCLI is a Buy.
What is BCLI’s 200-day moving average?
BCLI’s 200-day moving average is 0.69, which suggests BCLI is a Buy.
What is BCLI’s Williams % R (14)?
BCLI’s Williams % R (14) is -11.76, which suggests BCLI is a Sell.
What is BCLI’s CCI (14)?
BCLI’s CCI (14) is 140.57, which suggests BCLI is a Sell.